<HashMap><database>biostudies-arrayexpress</database><scores/><additional><submitter>Alexandre Favereaux</submitter><organism>Homo sapiens</organism><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-15636</full_dataset_link><description>Collagen tracks deposited by breast cancer cells contain specific miRNAs which reprogram non-invasive cells into highly pro-metastatic ones by inducing a partial epithelial–mesenchymal transition (EMT) associated with an increase in ECM degradation and cell invasiveness.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Nucleic Acid Extraction - RNA was extracted using the Direct-zol RNA microprep kit (Zymo Research) following manufacturer’s instructions, RNA purity was assessed by capillary electrophoresis (LabChip RNA pico sensitivity assay, Perkin Elmer). For MCF-7 cells internalization mRNA-seq RNA extraction was peformed using Nucleospin RNA kit (Macherey Nagel).</sample_protocol><sample_protocol>Sample Collection - For mRNA and microRNA seq of collagen-tracks, we compared a decellularized ECM decorated with collagen-tracks to a control ECM incubated with conditioned media from the same cells. For the track-containing sample, 140,000 MDA-DDR1-GFP cells were seeded on 4 silicone dishes previously coated with 0.5mg/ml type I collagen (Corning, prepared as previously described). The control dish was coated with 0.5mg/ml type I collagen incubated with conditioned media from the same MDA-DDR1-GFP cells. After an overnight incubation, cells were detached using 12 to 16 baths of 20mM EDTA for 5 min at 37°C. The remaining cells were removed by laser microdissection using PALM type 4 microscope (Zeiss). The decellularized ECM were then lysed with 300µl Trizol and kept at -80°C before being used.</sample_protocol><sample_protocol>Sequencing - Sequencing was performed on a NextSeq 2000 system (Illumina) in a 2x100bp mode.</sample_protocol><sample_protocol>Library Construction - Small-RNA-seq libraries were synthesized using NEXTflex Small-RNA Seq kit v3 (Perkin Elmer) following the manufacturer’s instructions. mRNA were reverse transcribed with an oligo-dT primer containing an adapter sequence and double-stranded cDNA was obtained with a template switching oligo (TSO) containing the same adapter sequence as the oligo-dT. After a pre-amplification with 15 cycles of PCR, we used the NEXTflex Rapid XP DNA-seq kit v2 (Perkin Elmer) to synthesize RNA-seq libraries.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><instrument_platform>Direct-zol RNA microprep kit (Zymo Research), LabChip RNA pico sensitivity assay, Perkin Elmer &amp;  Nucleospin RNA kit (Macherey Nagel)</instrument_platform><instrument_platform>NEXTflex Small-RNA Seq kit v3 (Perkin Elmer)  &amp; NEXTflex Rapid XP DNA-seq kit v2 (Perkin Elmer)</instrument_platform><instrument_platform>NextSeq 2000</instrument_platform><instrument_platform>PALM type 4 microscope (Zeiss)</instrument_platform><study_type>RNA-seq of total RNA</study_type><species>Homo sapiens</species><pubmed_title>Cancer cells transfer invasive properties through microRNAs contained in collagen-tracks</pubmed_title><pubmed_authors>Lucile Rouyer, Léa Normand, Elodie Richard, Nathalie Allain, Julie Giraud, Sylvaine Di-Tommaso, Cyril Dourthe, Anne-Aurélie Raymond, Jean-William Dupuy, Kevin Moreau, Richard Iggo, Gaetan McGrogan, Nathalie Dugot-Senant, Anthony Bouter, Sisareuth Tan, Alexandre Favereaux, Violaine Moreau, Reini F. Luco, Manon Ros, Frédéric Saltel</pubmed_authors><pubmed_authors>Alexandre Favereaux</pubmed_authors></additional><is_claimable>false</is_claimable><name>RNA-seq of cancer cell collagen tracks</name><description>Collagen tracks deposited by breast cancer cells contain specific miRNAs which reprogram non-invasive cells into highly pro-metastatic ones by inducing a partial epithelial–mesenchymal transition (EMT) associated with an increase in ECM degradation and cell invasiveness.</description><dates><release>2025-12-14T00:00:00Z</release><modification>2025-12-14T12:27:32.788Z</modification><creation>2025-09-25T20:45:11.932Z</creation></dates><accession>E-MTAB-15636</accession><cross_references><ENA>ERP180636</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0009653</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>